ALSO NOTED: Sanofi plans $100 million R&D facility; Vaccines safety group seeks public input; and much more...

Vaccine Research

Sanofi Pasteur is blueprinting plans for a $100 million R&D facility to develop new vaccines in Toronto. Report

Health and Human Services is giving Iomai the green light to do a mid-stage dose ranging study of its adjuvant patch for bird flu vaccine. HHS provided a $128 million contract backing Iomai's effort last year, and was rewarded with dramatic Phase I/II data on its ability to boost the effectiveness of bird flu vaccine. Report

Phase I/II trial results have shown that the live Listeria cancer vaccine, Lovaxin C, is safe for humans, according to data being presented at the 2008 Annual Meeting of the American Association for Cancer Research. In addition, four women with end-stage cancer in the cervical cancer trial experienced tumor reductions. Report

Two global research organizations dedicated to designing a vaccine against HIV-- the International AIDS Vaccine Initiative (IAVI), and the Center for HIV/AIDS Vaccine Immunology (CHAVI)--have signed an agreement to work together to address major biological questions that have slowed development of a safe, effective and affordable AIDS vaccine. Release

Early studies show that a new mucosal vaccine against anthrax has the potential to provide military personnel with more effective and efficient protection against a "popular" bioweapon, according to a study published in the journal Clinical and Vaccine Immunology. Release

Vaccine Market

Facing severe public skepticism, a government working group for vaccines plans to seek a considerable amount of public input before it picks which vaccine safety questions the CDC should investigate over the next five years. Report

Cases of life-threatening pneumonia are on the rise in the UK, and some health specialists say that the widespread use of a vaccine that protects children against common forms of pneumonia may be partly responsible. Article

An outbreak of measles has been reported in Arizona. Report

A new bill being debated in Louisiana would mandate vaccinations of all 11-year-olds against Meningicoccal diseases. Story

Annual flu vaccinations are highly effective at preventing acute respiratory illness and making sure that existing breathing problems don't get any worse, according to research published in the April issue of IJCP, the UK-based International Journal of Clinical Practice. Release

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.